Higher levels of PTX3 were observed in glioblastomas, whereas its expression in low‐grade gliomas and normal astrocytes is very low or null,60 and higher levels of PTX3 are associated with a high degree of malignancy and shorter patient survival.61 Here, PTX3 is linked to central nervous system cancer.